Back to results

CompletedPhase 3

Study of Combination Therapy With SYR-322

NCT01521962

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Aomori, Aomori, Japan

+32 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2012-02
Enrollment: 67 participants
Sponsor: Takeda

Locations (33)

Aomori, Aomori, Japan
Hirosaki-shi, Aomori, Japan
Kashiwa-shi, Chiba, Japan
Kisarazu-shi, Chiba, Japan
Kitakyushu-shi, Fukuoka, Japan
Aki-gun, Hiroshima, Japan
Fukuyama-shi, Hiroshima, Japan
Nishinomiya-shi, Hyōgo, Japan
Koga-shi, Ibaraki, Japan
Ushiku-shi, Ibaraki, Japan
Kahoku-gun, Ishikawa-ken, Japan
Hanamaki-shi, Iwate, Japan
Morioka, Iwate, Japan
Kagoshima, Kagoshima-ken, Japan
Satsuma-sendai-shi, Kagoshima-ken, Japan
Kumamoto, Kumamoto, Japan
Minamata-shi, Kumamoto, Japan
Miyazaki, Miyazaki, Japan
Nigata-shi, Niigata, Japan
Hirakata-shi, Osaka, Japan
Osaka, Osaka, Japan
Osaka-sayama-shi, Osaka, Japan
Takatsuki-shi, Osaka, Japan
Yao-shi, Osaka, Japan
Kuki-shi, Saitama, Japan
Ōtsu, Shiga, Japan
Hamamatsu, Shizuoka, Japan
Shizuoka, Shizuoka, Japan
Shimotsuke-shi, Tochigi, Japan
Shinagawa-ku, Tokyo, Japan
Toyama, Toyama, Japan
Sagae-shi, Yamagata, Japan
Yamagata, Yamagata, Japan

Study of Combination Therapy With SYR-322 — TrialFind